Global Viral Gastroenteritis Market Report 2024

Viral Gastroenteritis Global Market Report 2024 – By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdominal Cramps, Pain, Other Indications), By Type Of Virus (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus), By End User (Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Viral Gastroenteritis Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Viral Gastroenteritis Market Definition And Segments

Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

The main types of drugs in viral gastroenteritis are antibiotics, antacids, laxatives, antimotility agents, and others. Antacids refer to medicines that neutralize the acid in the stomach to relieve heartburn and indigestion. The various diagnosis includes a physical examination and a rapid stool test that is indicated by various indications such as watery diarrhea, abdominal cramps, pain, and others. The various types of viruses include norovirus, rotavirus, astrovirus, and enteric adenovirus. These are used by various end-users such as hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers, and others.

The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

The viral gastroenteritis market size has grown strongly in recent years. It will grow from $6.34 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to the prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, and climate and environmental factors.

The viral gastroenteritis market size is expected to see steady growth in the next few years. It will grow to $8.1 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to global health preparedness, climate change impact, one health approach, epidemiological surveillance systems, education and public awareness. Major trends in the forecast period include vaccine development, advanced diagnostics, telemedicine in diagnosis, collaborative research initiatives, personalized medicine approaches, and digital health solutions.

Rising Prevalence Of Gastrointestinal Disorders To Drive Market Growth

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the viral gastroenteritis market going forward. Gastrointestinal (GI) disorders refer to a disease that occurs within or on any part of the gastrointestinal tract. Viral gastroenteritis drugs and diagnosis treatments help people suffering from the illness with proper and appropriate medication. For instance, in October 2021, according to a survey report across 33 countries among 73,076 adults by Bodibio, a US-based fitness and wellness company, 40% of those surveyed had a functional gastrointestinal disorder, including all the variations of functional dyspepsia, irritable bowel syndrome, functional constipation, and others. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the viral gastroenteritis market.

Rising Emphasis On Hygiene And Sanitation To Drive Market Growth

The increasing awareness about hygiene and sanitation is expected to propel the growth of viral gastroenteritis market going forward. Hygiene encompasses personal behaviors like handwashing, waste disposal, and personal cleanliness to maintain a clean environment. Sanitation involves providing facilities for safe waste disposal, and water treatment, and ensuring a hygienic environment in homes, communities, and public spaces. Hygiene and sanitation are critical in preventing the transmission of viruses causing gastroenteritis. These measures help interrupt the fecal-oral route of transmission, reduce contamination, and contribute to overall community health by minimizing the risk and impact of viral gastroenteritis outbreaks. For instance, in September 2022, according to a survey conducted by Citron Hygiene, a Canada-based provider of washroom hygiene services, pre-pandemic just 11% of people washed their hands for the required 18–20 seconds, but during the pandemic, that number increased to 25%. Moreover, 67% of individuals feel the COVID-19 epidemic has increased their fear of germs and awareness of hygiene. Therefore, the increasing awareness about hygiene and sanitation is driving the growth of the viral gastroenteritis market.

Major companies operating in the viral gastroenteritis market report are Pfizer Inc., Abbvie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Daiichi Sankyo Company Limited, Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics PLC, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Ironwood Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan PLC, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

Product Innovations Transforming The Viral Gastroenteritis Market

Product innovation is the key trend gaining popularity in the viral gastroenteritis market. Major companies operating in the viral gastroenteritis market are focusing on developing new products to strengthen their position in the market. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its oral-dosing applicator-only presentation (liquid formulation) of ROTARIX to prevent rotavirus gastroenteritis in infants. This new presentation formulation becomes more convenient for healthcare providers by eliminating the need to reconstitute the vaccine dose at the point of use. The approval is supported by international clinical trial data demonstrating safety and tolerability compared to the lyophilized formulation and non-inferiority of immunogenicity.

Innovative PCR Kits Reshaping The Viral Gastroenteritis Market

Major companies operating in the viral gastroenteritis market are developing new products such as PCR kits for gastrointestinal infectious diseases to gain a competitive edge in the market. PCR kits, or Polymerase Chain Reaction kits, are molecular biology tools designed for the amplification and detection of specific DNA sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based molecular diagnostic solutions company, launched 10 Real-Time PCR Kits designed for accurate detection of gastrointestinal pathogens, forming a comprehensive Total PCR Solution when integrated with their extraction solution and PCR system. The Real-Time PCR Kits cover a range of bacterial, viral, and parasitic pathogens associated with gastrointestinal infections. These include diseases caused by various bacterial pathogens such as Campylobacter, Salmonella, Shigella, and Clostridioides difficile, as well as viral agents like Adenovirus, Rotavirus, Astrovirus, and Norovirus. This innovative solution provides a streamlined approach from sample pre-processing to PCR amplification analysis.

Hologic Inc. Expands Diagnostic Reach Through Acquisition Of Diagenode

In March 2021, Hologic Inc., a US-based medical technology company, acquired Diagenode for $159 million. Through this acquisition, Hologic expands and diversifies its diagnostic business across customer segments, test menus, and geography. The company aims to accelerate and broaden efforts to benefit customers and patients. Diagenode is a Belgium-based diagnostic assay manufacturer that offers more than 30 real-time CE-marked PCR (polymerase chain reaction) tests to detect bacteria, parasites, and viruses involved in various infections, meningitis, respiratory diseases, and gastroenteritis.

North America was the largest region in the viral gastroenteritis market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viral gastroenteritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral gastroenteritis market consists of revenues earned by entities by providing various diagnostics such as polymerase chain reaction testing and immunoassays. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral gastroenteritis market also includes sales of antiemetics, and chemotherapy drugs used for treating viral gastroenteritis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The viral gastroenteritis market research report is one of a series of new reports from The Business Research Company that provides viral gastroenteritis market statistics, including viral gastroenteritis industry global market size, regional shares, competitors with a viral gastroenteritis market share, detailed viral gastroenteritis market segments, market trends, and opportunities, and any further data you may need to thrive in the viral gastroenteritis industry. This viral gastroenteritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Viral Gastroenteritis Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $6.7 billion
Revenue Forecast In 2033 $8.1 billion
Growth Rate CAGR of 4.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Abbvie Inc.; Bayer AG; Sanofi S.A.; AstraZeneca Plc.; Abbott Laboratories; GlaxoSmithKline Plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; C.H. Boehringer Sohn AG & Co. KG; Daiichi Sankyo Company Limited; Regeneron Pharmaceuticals Inc.; Mylan N.V.; Astellas Pharma Inc.; Fresenius Kabi AG; Bausch Health Companies Inc.; Alexion Pharmaceuticals Inc.; Horizon Therapeutics Plc; Dr. Reddy’s Laboratories Ltd.; BioMarin Pharmaceutical Inc.; Lupin Limited; Zydus Lifesciences Limited; Alkem Laboratories Ltd; Ironwood Pharmaceuticals Inc; ANI Pharmaceuticals Inc.; Merck Sharp & Dohme Corp.; Allergan plc; Haustus Biotech Private Limited; Gracia Lifesciences India Private Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Viral Gastroenteritis Market Characteristics

    3. Viral Gastroenteritis Market Trends And Strategies

    4. Viral Gastroenteritis Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Viral Gastroenteritis Market Size and Growth

    5.1. Global Viral Gastroenteritis Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Viral Gastroenteritis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Viral Gastroenteritis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Viral Gastroenteritis Market Segmentation

    6.1. Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Antibiotics

    Antacids

    Laxatives

    Antimotility Agents

    Others Drugs

    6.2. Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Physical Examination

    Rapid Stool Test

    6.3. Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Watery Diarrhea

    Vomiting

    Abdominal Cramps

    Pain

    Other Indications

    6.4. Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Norovirus

    Rotavirus

    Astrovirus

    Enteric Adenovirus

    6.5. Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Clinics

    Pharmaceutical Companies

    Diagnostic Centers

    Ambulatory Care Centers

    Others End Users

    7. Viral Gastroenteritis Market Regional And Country Analysis

    7.1. Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Viral Gastroenteritis Market

    8.1. Asia-Pacific Viral Gastroenteritis Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Viral Gastroenteritis Market

    9.1. China Viral Gastroenteritis Market Overview

    9.2. China Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Viral Gastroenteritis Market

    10.1. India Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Viral Gastroenteritis Market

    11.1. Japan Viral Gastroenteritis Market Overview

    11.2. Japan Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Viral Gastroenteritis Market

    12.1. Australia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Viral Gastroenteritis Market

    13.1. Indonesia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Viral Gastroenteritis Market

    14.1. South Korea Viral Gastroenteritis Market Overview

    14.2. South Korea Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Viral Gastroenteritis Market

    15.1. Western Europe Viral Gastroenteritis Market Overview

    15.2. Western Europe Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Viral Gastroenteritis Market

    16.1. UK Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Viral Gastroenteritis Market

    17.1. Germany Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Viral Gastroenteritis Market

    18.5. France Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Viral Gastroenteritis Market

    19.9. Italy Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Viral Gastroenteritis Market

    20.13. Spain Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Viral Gastroenteritis Market

    21.1. Eastern Europe Viral Gastroenteritis Market Overview

    21.2. Eastern Europe Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Viral Gastroenteritis Market

    22.1. Russia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Viral Gastroenteritis Market

    23.1. North America Viral Gastroenteritis Market Overview

    23.2. North America Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Viral Gastroenteritis Market

    24.1. USA Viral Gastroenteritis Market Overview

    24.2. USA Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Viral Gastroenteritis Market

    25.1. Canada Viral Gastroenteritis Market Overview

    25.2. Canada Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Viral Gastroenteritis Market

    26.1. South America Viral Gastroenteritis Market Overview

    26.2. South America Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Viral Gastroenteritis Market

    27.1. Brazil Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Viral Gastroenteritis Market

    28.1. Middle East Viral Gastroenteritis Market Overview

    28.2. Middle East Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Viral Gastroenteritis Market

    29.1. Africa Viral Gastroenteritis Market Overview

    29.2. Africa Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Viral Gastroenteritis Market Competitive Landscape And Company Profiles

    30.1. Viral Gastroenteritis Market Competitive Landscape

    30.2. Viral Gastroenteritis Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. AbbVie Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bayer AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi S.A.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca Plc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Viral Gastroenteritis Market Other Major And Innovative Companies

    31.1. Abbott Laboratories

    31.2. GlaxoSmithKline Plc.

    31.3. Takeda Pharmaceutical Company Limited

    31.4. Eli Lilly and Company

    31.5. Amgen Inc.

    31.6. C.H. Boehringer Sohn AG & Co. KG

    31.7. Daiichi Sankyo Company Limited

    31.8. Regeneron Pharmaceuticals Inc.

    31.9. Mylan N.V.

    31.10. Astellas Pharma Inc.

    31.11. Fresenius Kabi AG

    31.12. Bausch Health Companies Inc.

    31.13. Alexion Pharmaceuticals Inc.

    31.14. Horizon Therapeutics Plc

    31.15. Dr. Reddy’s Laboratories Ltd.

    32. Global Viral Gastroenteritis Market Competitive Benchmarking

    33. Global Viral Gastroenteritis Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Viral Gastroenteritis Market

    35. Viral Gastroenteritis Market Future Outlook and Potential Analysis

    35.1 Viral Gastroenteritis Market In 2028 - Countries Offering Most New Opportunities

    35.2 Viral Gastroenteritis Market In 2028 - Segments Offering Most New Opportunities

    35.3 Viral Gastroenteritis Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: AbbVie Inc. Financial Performance
  • Table 78: Bayer AG Financial Performance
  • Table 79: Sanofi S.A. Financial Performance
  • Table 80: AstraZeneca Plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: AbbVie Inc. Financial Performance
  • Figure 78: Bayer AG Financial Performance
  • Figure 79: Sanofi S.A. Financial Performance
  • Figure 80: AstraZeneca Plc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Forklift Truck Global Market Report 2024 – By Product Type (Counterbalance, Warehouse), By Technology (Electric Power, Internal Combustion Engine), By Class (Class I, Class II, Class III, Class IV, Class V), By End-User (Retail and Wholesale, Logistics, Automotive, Food Industry, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Sale Terminals Global Market Report 2024 – By Product (Mobile, Fixed), By Component (Hardware, Software, Service), By Technology (Biometric, Traditional), By Operating System (Windows, Linux, MAC), By Application  (Restaurants, Hospitality, Healthcare, Retail, Warehouse, Entertainment, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Warehouse Execution System Global Market Report 2024 – By Component (Software, Service), By Deployment (On-Premises, Cloud), By End User (Consumer Electronics, Healthcare, Food And Beverages, Automotive, Third-Party Logistics (3PL), Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Smart And Mobile Supply Chain Solutions Global Market Report 2024 – By Solution (Transportation Management Systems (TMS), Warehouse Management Systems (WMS), Sourcing and Procurement, Supply Chain Planning (SCP), Manufacturing Execution Systems (MES)), By Enterprise Size (Small and Medium Enterprises, Large Enterprises), By End-User (Retail and Consumer Goods, IT and Telecom, Manufacturing, BFSI, Government, Energy and Utilities, Healthcare, Transportation and Logistics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Warehousing And Storage Global Market Report 2024 – By Type (General Warehousing And Storage, Refrigerated Warehousing And Storage, Specialized Warehousing And Storage, Farm Product Warehousing And Storage), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses, Cooperative Warehouses), By End-Use (Retail Industry, Manufacturing Industry, Consumer Goods Industry, Food And Beverages Industry, Healthcare Industry, E-Commerce, Other End Use) – Market Size, Trends, And Global Forecast 2024-2033
View Report
General Warehousing And Storage Global Market Report 2024 – By Type (Bonded Warehousing, Private Warehousing and Storage, and Warehousing (including foreign trade zones)), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses), By End User (Manufacturing, Consumer Goods, Retail, Food and Beverages, IT Hardware, Healthcare, Chemicals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Refrigerated Warehousing And Storage Global Market Report 2024 – By Type (Cold Storage, Frozen Storage), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses), By Application (Fruits & Vegetables, Bakery & Confectionery, Milk & Dairy Products, Meat, Seafood, Beverages, Other Applications)– Market Size, Trends, And Global Forecast 2024-2033
View Report
Specialized Warehousing And Storage Global Market Report 2024 – By Type (Automobile Dead Storage, Bulk Petroleum And Chemical Storage, Document Storage And Warehousing, Whiskey Warehousing, Other Specialized Warehousing And Storage), By Ownership (Private Warehouses, Public Warehouses, Bonded Warehouses), By End-Use (Retail Industry, Manufacturing Industry, Consumer Goods Industry, Food & Beverage Industry, Healthcare Industry, Other End Users)– Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the viral gastroenteritis market?

Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever. For further insights on the viral gastroenteritis market, request a sample here

How will the viral gastroenteritis market drivers and restraints affect the viral gastroenteritis market dynamics? What forces will shape the viral gastroenteritis industry going forward?

The viral gastroenteritis market major growth driver - Rising Prevalence Of Gastrointestinal Disorders To Drive Market Growth. For further insights on the viral gastroenteritis market, request a sample here

What is the forecast market size or the forecast market value of the viral gastroenteritis market?

The viral gastroenteritis market size has grown strongly in recent years. It will grow from $6.34 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, climate and environmental factors. The viral gastroenteritis market size is expected to see steady growth in the next few years. It will grow to $8.1 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to global health preparedness, climate change impact, one health approach, epidemiological surveillance systems, education and public awareness. Major trends in the forecast period include vaccine development, advanced diagnostics, telemedicine in diagnosis, collaborative research initiatives, personalized medicine approaches, digital health solutions. For further insights on the viral gastroenteritis market, request a sample here

How is the viral gastroenteritis market segmented?

The viral gastroenteritis market is segmented
1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End UsersFor further insights on the viral gastroenteritis market, request a sample here

Which region has the largest share of the viral gastroenteritis market? What are the other regions covered in the report?

North America was the largest region in the viral gastroenteritis market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the viral gastroenteritis market, request a sample here.

Who are the major players in the viral gastroenteritis market?

Major companies operating in the viral gastroenteritis market report are Pfizer Inc., Abbvie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Daiichi Sankyo Company Limited, Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited For further insights on the viral gastroenteritis market, request a sample here.

What are the key trends in the viral gastroenteritis market?

Major trend in the viral gastroenteritis market - Product Innovations Transforming The Viral Gastroenteritis Market. For further insights on the viral gastroenteritis market, request a sample here.

What are the major opportunities in the viral gastroenteritis market? What are the strategies for the viral gastroenteritis market?

For detailed insights on the major opportunities and strategies in the viral gastroenteritis market, request a sample here.

How does the viral gastroenteritis market relate to the overall economy and other similar markets?

For detailed insights on viral gastroenteritis market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the viral gastroenteritis industry?

For detailed insights on the mergers and acquisitions in the viral gastroenteritis industry, request a sample here.

What are the key dynamics influencing the viral gastroenteritis market growth? SWOT analysis of the viral gastroenteritis market.

For detailed insights on the key dynamics influencing the viral gastroenteritis market growth and SWOT analysis of the viral gastroenteritis industry, request a sample here.